cancer

FDA approves rare blood cancer drug

According to Reuters, the US Food and Drug Administration has approved a rare blood cancer drug called Besponsa.

The drug was produced by big pharma company Pfizer Inc. Besponsa will be used to treat adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (ALL).

This type of cancer causes bone marrow to produce too many B-Cell lymphocytes, an immature white blood cell.

Besponsa is a targeted therapy that binds to B-cell ALL cancer cells that expresses the CD22 antigen, blocking the growth of cancer cells.

Calgary's Sofia Smith captures hearts worldwide after shaving head for cancer

When Sofia Smith stood on her school’s stage to say goodbye to her long blonde hair last month, eyes full of tears, she never imagined the international attention she would receive.

The nine-year-old had shaved her head to raise more than $20,000 dollars in support of Calgary charity Kids Cancer Care in Canada in solidarity with her older brother Rand, who had been diagnosed with cancer earlier just a few months before.

“I was thinking about how many lives I’ve just changed and how it can change my brother’s life,” Smith said shortly after the event.

World: Bollywood star Vinod Khanna dies of cancer

One of India's most well-known Bollywood actors Vinod Khanna has died aged 70, his hospital has confirmed.

Khanna, also an active politician, had been suffering from cancer and was admitted to hospital earlier this month as his illness became more serious.

He acted in more than 100 Bollywood films and was widely seen as a counterfoil to the "angry young man" played by Amitabh Bachchan.

He was elected to parliament four times and was once a junior foreign minister.

Supply of cancer medication due in country from September 1st

A shipment of cancer medication will arrive in the country anytime from Thursday this week to late next week, a statement from the Ministry of Health say.

The Ministry issued a statement today in light of the concerns about a shortage of medication.

The following is the Ministry's statement.

Pages